www.fdanews.com/articles/197014-moderna-plans-phase-3-trial-of-covid-19-vaccine-for-early-summer
![Moderna logo](https://www.fdanews.com/ext/resources/test/Drug-Images4/Moderna-logo.jpg?t=1589311392&width=430)
Moderna Plans Phase 3 Trial of COVID-19 Vaccine for Early Summer
May 8, 2020
Moderna said it is planning to begin phase 3 trials of its COVID-19 vaccine candidate by early summer, accelerating the timeline for getting a vaccine to market.
The FDA has already cleared the vaccine candidate, mRNA-1273, for a phase 2 two trial in approximately 600 participants.
Moderna CEO Stephane Bancel said the company hopes to have the vaccine approved early next year.